Why the 49ers’ New Signings Could Be a Gamble Worth Taking

Bold Moves or A House of Cards?

The San Francisco 49ers have been lauded for their shrewd free-agent signings this offseason—but not everyone is sold. A league executive fired a warning shot at the team’s high-risk strategy, targeting two of its marquee acquisitions:

• Mike Evans, the veteran wide receiver on the wrong side of 33, who has suited up for fewer than 15 games in two of the last three seasons.
• Dre Greenlaw, a linebacker with a spotty injury history, whose durability has been as inconsistent as his production.

Critics argue the duo’s health concerns could derail San Francisco’s championship aspirations before the season even begins. Meanwhile, the 49ers remain undeterred, banking on a financially savvy contract structure to insulate themselves from the pitfalls.

The 49ers’ Safety Net: One-Year Temptations and Performance Clauses

San Francisco’s front office didn’t blindly dive into the deep end—it constructed deals designed to minimize downside.

• Evans’ contract? A one-year stopgap with a clean escape hatch, ensuring the team isn’t locked into a long-term liability if his knees give out.
• Greenlaw’s deal? Packed with performance-based incentives that only materialize if he stays upright—a cunning way to offload financial risk.

This low-stakes, high-upside approach has sparked widespread praise. After losing Jauan Jennings, the 49ers needed a proven receiver who aligned with their offensive identity—and Evans, despite his injury woes, still brings the goods when he’s on the field.

But is it worth the gamble?

---

Why Roll the Dice on Fragile Talent?

The answer lies in the brutal math of the NFC West.

With the Seattle Seahawks and Los Angeles Rams flexing their financial muscles year after year, the 49ers can’t afford to lag behind. In a division where superteams clash year-round, San Francisco is playing a dangerous game of offseason leapfrog—one where taking calculated risks isn’t just encouraged, it’s necessary.

Signing high-profile but injury-prone veterans isn’t just alchemy; it’s strategic necessity. The question isn’t whether Evans or Greenlaw will stay healthy—it’s whether either one’s peak production justifies the gamble.

Because in the NFC West, standing pat isn’t an option. Sometimes, the biggest reward comes from betting on a comeback that may never happen.